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Identification and Functional Characterization of Rca1, a Transcription Factor Involved in both Antifungal Susceptibility and Host Response in Candida albicans
The identification of novel transcription factors associated with antifungal response may allow the discovery of fungus-specific targets for new therapeutic strategies. A collection of 241 Candida albicans transcriptional regulator mutants was screened for altered susceptibility to fluconazole, caspofungin, amphotericin B, and 5-fluorocytosine. Thirteen of these mutants not yet identified in terms of their role in antifungal response were further investigated, and the function of one of them, a mutant of orf19.6102 (RCA1), was characterized by transcriptome analysis. Strand-specific RNA sequencing and phenotypic tests assigned Rca1 as the regulator of hyphal formation through the cyclic AMP/protein kinase A (cAMP/PKA) signaling pathway and the transcription factor Efg1, but also probably through its interaction with a transcriptional repressor, most likely Tup1. The mechanisms responsible for the high level of resistance to caspofungin and fluconazole observed resulting from RCA1 deletion were investigated. From our observations, we propose that caspofungin resistance was the consequence of the deregulation of cell wall gene expression and that fluconazole resistance was linked to the modulation of the cAMP/PKA signaling pathway activity. In conclusion, our large-scale screening of a C. albicans transcription factor mutant collection allowed the identification of new effectors of the response to antifungals. The functional characterization of Rca1 assigned this transcription factor and its downstream targets as promising candidates for the development of new therapeutic strategies, as Rca1 influences host sensing, hyphal development, and antifungal response.
C
andida albicans is a commensal yeast in humans. This yeast can persistently colonize skin and mucosal surfaces. However, C. albicans can cause a wide spectrum of diseases, ranging from mucosal infections such as oral thrush to fatal disseminated candidiasis. Oral and vaginal infections with C. albicans are extremely common even in weakly immunocompromised individuals. In severe immunodeficiency, C. albicans penetrates into deeper tissues and may enter the bloodstream. From the bloodstream, the fungus has the potential to invade almost all body sites and organs and leads in these cases to high mortality (40 to 60%) (28) . The fight against C. albicans infections necessitates the use of antifungal agents. Current available antifungal drugs belong to 4 major different classes: the polyenes, the azoles, the pyrimidine analogues, and the echinocandins. Each of these classes contains different compounds with specific ranges of activities against the major fungal pathogens (polyenes, i.e., amphotericin B [AMB] and nystatin; azoles, i.e., fluconazole [FLC] , itraconazole, and voriconazole; a pyrimidine analogue, i.e., 5-fluorocytosine [5FC]; and echinocandins, i.e., caspofungin [CAS] ). Their activity against common fungal pathogens and their mode of action are summarized in several available reviews (2, 5, 53) .
The exposure of fungal pathogens to antifungal agents has different outcomes. First, fungal pathogens can exhibit short-term and long-term transient responses as the result of short (a few minutes) or long (several hours) drug exposure that include changes in the transcriptional activity of groups of genes and activation of signaling pathways. The transient responses of fungal pathogens to antifungal agents have been investigated using genome-wide transcriptome approaches. In general, groups of genes affected by drug exposure corresponded to those belonging to the pathway targeted by a given drug. For example, FLC exposure of C. albicans results in the enhanced expression of genes of the ergosterol biosynthetic pathway, including ERG2, ERG3, ERG10, ERG25, ERG251, and ERG11, which is the target of azoles (40) . Treatment of C. albicans with CAS, a drug targeting ␤-1,3 glucan synthase complex, rapidly induces a set of genes required for cell wall maintenance and architecture (7, 40) . Several microarray experiments have also been performed with C. albicans exposed to AMB and 5FC (7, 40) .
Fungal pathogens can also engage mechanisms enabling their survival in the presence of fungistatic antifungal agents. The survival mechanisms are generally understood as tolerance mechanisms. Lastly, fungal pathogens can undergo alterations in their genomes (i.e., mutations) that arise from positive genetic selection due to the presence of antifungals, resulting in resistance to drugs. This allows growth at high drug concentrations that are otherwise detrimental to the pathogen. Among the known mutations involved in drug resistance, transcription factors (TFs) play an important role. This is probably not too surprising since resistance mechanisms often involve the upregulation of antifungal target genes, which themselves are controlled by specific transcription factors. For example, Tac1 controls the expression of the efflux transporters CDR1 and CDR2 (15) , while Mrr1 and Upc2 control the expression of MDR1 and ERG11, respectively (50) . Mutations in these factors result in an enhanced transcriptional activation of target genes, and this was demonstrated for Tac1 (14, 15) , Mrr1 (43) , and Upc2 (20, 56) .
Interestingly, the absence of the above-mentioned transcription factors does not completely abolish the transcriptional response of C. albicans to antifungal agents, as judged by wholegenome transcript profiling experiments (7, 70) . Moreover, little is known about transcriptional activators regulating the response to other antifungal agents such as 5FC and AMB. It is therefore likely that other, yet-unidentified transcription factors can still participate in the response of C. albicans to antifungal agents. Other studies have identified transcriptional regulators of drug resistance by functional complementation or systematic mutant screenings. For example, NDT80, a C. albicans gene similar to the Saccharomyces cerevisiae NDT80 gene (a meiosis-specific gene belonging to the Ig fold family of transcription factors [38] ), was identified by its ability to regulate the C. albicans gene CDR1 in S. cerevisiae. NDT80 inactivation in C. albicans did result in a decreased basal CDR1 expression and a decreased CDR1 induction in the presence of drugs (11) . A recent study supports this hypothesis by showing direct binding of Ndt80 to the CDR1 promoter (54). Rauceo et al. (48) identified Sko1, a bZip transcriptional activator, as a regulator of CAS susceptibility in C. albicans. This gene is under the control of the Hog1 pathway and controls the expression of several genes among which are cell wall biosynthesis genes (CRH11 and MNN2). Likewise, the TF Cas5 was reported as critical for the response of C. albicans to the class of echinocandins targeting cell wall biosynthesis (7); however, no CAS resistance mechanism has yet been associated with CAS5 mutations.
In order to identify additional regulators of the response to antifungal agents, large-scale screening procedures using a collection of mutants with changes in genes encoding known and putative transcription factors of C. albicans have been carried out. In one study, Homann et al. (29) used a library of TF mutants and subjected their collection to different drug screenings. In addition to several known TFs involved in drug response, that study identified several other potential regulators of drug resistance; however, their precise role was not further investigated.
In this study, we identified several TFs, the absence of which increased or decreased susceptibility to specific antifungal agents. We describe several novel phenotypes that constitute the basis for their further characterization. We report the detailed characterization of orf19.6102 (RCA1), which controls the response of C. albicans to both FLC and CAS. Transcriptome analyses coupled with additional phenotypic assays allowed identification of this TF as a regulator of hyphal development in the presence of high carbon dioxide partial pressure (ppCO 2 ). Indeed, if high carbon dioxide partial pressure is well established as a condition promoting hyphal development in C. albicans, the molecular mechanisms underlying this induction were not understood until now. Here, we give experimental evidence for the involvement of Rca1 in hyphal development through its regulation of the cyclic AMP/ protein kinase A/Efg1 (cAMP/PKA/Efg1) signaling pathway and its putative interaction with a transcriptional repressor that remains to be identified. Table S1 in the supplemental material). Among these 274 genes, which belong either to transcription factors sensu stricto or to general regulators of transcription (e.g., RNA polymerase subunits, histone deacetylases, and SAGA complex), we obtained 241 homozygous mutants by four different methods. Most of them (183/241; ϳ75%) were obtained by UAU transposition (17) ; the remaining were obtained by the Ura-blaster method (24) and by PCR product recombination either from pFA plasmid (26) or from the use of the UAU disruption cassette (17) . Two different parental strains were used to create these mutants, CAF4-2 (24) for Ura-blaster-based mutants and BWP17 (67) for the remaining mutants. Thus, three different wild-type marker-matched strains, i.e., PVY121 (CAF4-2 background, rendered Ura ϩ by integration of the CIp10 plasmid [44] at the RPS1 locus), DAY286 (BWP17 background, Arg ϩ Ura ϩ His Ϫ ), and SFY87 (BWP17 background, rendered Arg ϩ Ura ϩ His ϩ by integration of the CIp30 plasmid [18] at the RPS1 locus), were used as controls. A total of 222 mutants of this collection were already deposited and are publicly available at the Fungal Genetics Stock Center (http://www.fgsc.net).
MATERIALS AND METHODS

C. albicans transcription factor mutant collection.
Strains and plasmids. All plasmids listed in Table S2 in the supplemental material were propagated in Escherichia coli strain DH5␣ grown in Luria-Bertani broth (yeast extract, 5 g/liter; peptone, 10 g/liter; NaCl, 10 g/liter; agar, 20 g/liter whenever appropriate) supplemented with 100 g/ml of ampicillin. Besides strains of the TF mutant collection, yeast strains used throughout this study are listed in Table S3 in the supplemental material. The EFG1 deletion strain in the CAF4-2 background (HLC67) was a kind gift from the Fink laboratory (Withehead Institute for Biomedical Research, Cambridge, MA).
Serial dilution assays. Susceptibility of TF mutants to systemic antifungals was determined by comparison with their respective isogenic parental strains by serial dilution assay. Briefly, overnight cultures in YEPD medium (containing yeast extract, 5 g/liter; peptone, 10 g/liter; and glucose, 20 g/liter) were diluted in sterile phosphate-buffered saline (PBS) to a density of 2.5 ϫ 10 7 cells/ml, and serial 10-fold dilutions were performed in PBS to reach a density of 2.5 ϫ 10 2 cells/ml in the last dilution. Fourmicroliter drops of each dilution containing from 10 5 to 1 cell(s) were spotted onto YEPD agar plates supplemented with fluconazole (FLC; 2.5 g/ml), amphotericin B (AMB; 1 g/ml), or caspofungin (CAS; 0.075 g/ml) and onto drug-free YEPD agar plates as a reference condition. Susceptibility to 5-fluorocytosine (5FC) was determined on synthetic complete medium (SC medium; 6.7 g/liter of yeast nitrogen base [YNB; Difco], 0.79 g/liter of complete supplement mixture [CSM; MP Biochemicals], 20 g/liter of glucose, and 20 g/liter of agar) and not on YEPD medium since cytosine present in yeast extract competes with 5FC for incorporation into yeast cells. Susceptibility to 5FC was determined at 4 g/ml.
Since several inactivation strategies and therefore several parent strains were used to create the TF mutant collection, drug concentrations were optimized for the TF mutant collection screening. They correspond to the concentrations for which the phenotypes were the most obvious compared to the susceptibility of the wild-type reference strains. For convenience, the whole collection was kept at Ϫ80°C in 20% glycerol in 96-well plates, and overnight cultures were inoculated from these glycerol plates but each mutant was also cryopreserved individually. To ascertain the reproducibility of the results, the entire collection was screened on 2 independent occasions and the phenotypes of each mutant that displayed an increased or a decreased susceptibility during one of these two first screens were verified from individual original stocks. A phenotype was considered consistent when one of the first susceptibility assays and that from individual stocks gave the same results.
In some experiments, serial dilution assays were also performed to determine C. albicans susceptibility to other chemical compounds (all purchased from Sigma-Aldrich: 100 g/ml of calcofluor white, 100 g/ml of Congo red, 0.02% sodium dodecyl sulfate, 5 g/ml of MDL12-330A, and 150 M bathophenanthroline disulfonic acid), alone or in combination with antifungals. After both 24 and 48 h of incubation at 35°C, pictures of plates were taken and results were interpreted for each mutant as an enhanced or a reduced growth capacity in the presence of the drug(s) by comparison to wild-type strains.
Yeast transformation. Yeasts were transformed by following the lithium acetate procedure as already described (51) .
Construction of deletion and revertant strains for selected TFs. Genes encoding selected TFs were deleted independently according to the Ura-blaster strategy (24) . Briefly, TF loci, including 500 bp upstream and downstream of the coding region, were PCR amplified from CAF2-1 genomic DNA and cloned at the BamHI (or XbaI) and XhoI sites of pBluescript KSϩ (Stratagene), except for orf19.7381, which was cloned at the SacI and SphI sites of pMTL21 (9) . Inverse PCR was used to subclone 5= and 3= regions of TF genes into PstI (except HindIII for orf19.2545, KpnI for orf19.7381, and SphI for orf19.2747) and BglII sites of pMB-7. Whenever required, two deletion cassettes were created, one targeting the entire ORF and the second targeting an internal region. Ura-blaster deletion cassettes were released from pMB-7 by ApaI (or SphI for orf19.7381 and KpnI for orf19.2474) and SacI and were transformed into strain CAF4-2. Heterozygous mutants, selected onto YNB-ura, were plated onto YNB plates containing 0.34 mg/liter of fluoroorotic acid (FOA) to promote the excision of URA3 gene, and the Ura-blaster cassettes were used to delete the second allele. Homozygous deletion was verified by PCR using primers amplifying either the entire ORF or, in some cases, selectively only wild-type alleles and confirmed by Southern blotting. URA3 gene position within the TF mutant genome was normalized at the RPS1 locus by restoring uridine prototrophy with the CIp10 plasmid (44) . Moreover, revertant strains were constructed by introduction at the RPS1 locus of the TF ORF with 500 bp of upstream and downstream regions after cloning at the XhoI and MluI sites into CIp10 and linearization with StuI. Primers used to construct these strains are listed in Table S4 in the supplemental material. See also Fig. S1 to S4 in the supplemental material for the design of deletion cassettes.
Transcriptome analysis. The genes differentially expressed between the RCA1 mutant and revertant strains (strains PVY117 and PVY127, respectively) were identified by strand-specific RNA sequencing (RNAseq).
(i) RNA extraction. Total RNAs were extracted in duplicates from RCA1 mutant and revertant strains grown in 10 ml of YEPD medium until cultures reached mid-exponential growth phase (ϳ2.5 ϫ 10 7 cells/ml), by following a phenol-chloroform/lithium chloride procedure (15) . Contaminating genomic DNA was removed by DNase treatment (DNA-free; Ambion).
(ii) Strand-specific cDNA library preparation and sequencing. mRNAs were purified from total RNAs using magnetic beads coated with oligo(dT) (DynaBeads mRNA purification kit; Invitrogen) and then fragmented in approximately 80-mers by 3 min of incubation at 70°C with RNA fragmentation reagent (Ambion). After a second purification step with magnetic beads (RNAClean XP beads; Beckman Coulter), mRNAs were treated successively with alkaline phosphatase (New England BioLabs) and polynucleotide kinase (New England BioLabs) to restore 5=-phosphate groups leaked at the fragmentation step. Thereafter, 5=-adapter was ligated at the 5= end of mRNAs using a truncated T4 RNA ligase 2 (New England BioLabs), which is able to ligate fragments at the 5= end only. Next, the 3=-adapter was ligated using standard T4 RNA ligase (New England BioLabs) at the 3= end only, since this oligonucleotide is locked at its 3= end with a dideoxycytosine. cDNAs were obtained from these ligated mRNAs by a standard reverse transcription step using Superscript II reverse transcriptase (Invitrogen) and priming with an oligonucleotide complementary to the 5= adapter (SRA-RT). These cDNAs were briefly amplified by PCR with a high-fidelity polymerase (Phusion DNA polymerase; Finnzymes) and primers complementary to the 5= and 3= adapters (GX1 and GX2, respectively) using the following amplification protocol: 10 s at 98°C and then 12 cycles of 10 s at 98°C, 30 s at 60°C, and 15 s at 72°C, followed by a final step at 72°C for 10 min. The PCR products were then purified with magnetic beads (AMPure bead solution; Beckman Coulter) and quantified with a Qubit 2.0 fluorometer (Invitrogen), and the mean size of the fragments was determined by microelectrophoresis (BioAnalyzer 2100; Agilent). Sequences were resolved by ultrahigh-throughput sequencing on an Illumina Genome Analyzer IIx sequencer. Primers and adapters used to prepare strand-specific cDNA libraries are described in Table S4 in the supplemental material.
(iii) Signal quantification. Purity-filtered reads were aligned against the C. albicans SC5314 genome (assembly 21 s01-m02-r04) using TopHat (63) . The number of read counts per gene was summarized with HTSeq (http://www-huber.embl.de/users/anders/HTSeq) using a gene annotation file from the Candida Genome Database corresponding to the proper assembly. Normalization and differential gene expression analysis were carried on count data in R software (http://www.r-project.org) using the DESeq package (3) . Genes with a false discovery rate smaller than 5% and an absolute fold change larger than 2 were selected for further analysis. Exon position and coverage were quantified and detected with the Cufflinks package (http://cufflinks.cbcb.umd.edu/index.html). Splicing raw data are available in Table S5 in the supplemental material.
(iv) Result interpretation. Gene ontology (GO) analyses were performed on gene lists obtained by RNAseq to identify putative enriched biological functions, processes, or cell compartments (Candida Genome Database GO Term Finder; http://www.candidagenome.org/cgi-bin /GO/goTermFinder) and to assign differentially regulated genes to specific biological processes (Candida Genome Database GO Slim Mapper; http://www.candidagenome.org/cgi-bin/GO/goTermMapper). RNAseq data are available at NCBI under GEO accession number GSE37682.
(v) qPCR validation. To validate strand-specific RNAseq data, the expression levels of seven genes (i.e., HWP1, ECE1, PGA13, CDR4, OCH1, CHT2, and HGC1) were also quantified by quantitative PCR (qPCR) after reverse transcription. Briefly, RNAs were extracted as described above from three independent cultures of either the RCA1 mutant or revertant strains in YEPD medium and reverse transcribed using random hexamers as a priming method (Transcriptor first-strand cDNA synthesis kit; Roche). Expression levels were determined as described elsewhere (23) by SYBR green-based qPCR (MesaBlue qPCR kit for SYBR assay; Eurogentec) on a StepOne Plus real-time thermal cycler (Applied Biosystems), using standard curves for each gene and the expression level of ACT1 for normalization. See Table S4 for primer sequences.
Morphological studies. Hyphal development in C. albicans was assessed in 96-well microtiter plates by inoculating 200 l of YEPD medium at a density of 2.5 ϫ 10 4 cells/ml with an overnight culture. Hyphal development was induced either by incubating microtiter plates at 37°C in a 5% CO 2 atmosphere (IG150 incubator; Jouan) or by adding fetal calf serum (FCS; final concentration, 10%; Sigma-Aldrich) in the medium. As a control for yeast morphology, a microtiter plate was also incubated in YEPD medium at 30°C. After 3 to 4 h of incubation, pictures were taken directly from the microtiter plates with an inverted microscope (Axiovert200; Zeiss) equipped with a DX30 camera (Kappa), and the ratio of hyphae versus yeasts was visually quantified. For some experiments, MDL12-330A hydrochloride (Sigma-Aldrich) was added to the medium at 20 g/ml. All experiments were performed on three independent cultures of each strain under each condition tested.
As hyphal formation also influences invasive growth and macroscopic aspect of colonies, the ability of C. albicans to invade the agar-based substrate was assessed by inspecting YEPD agar plates incubated for 48 h at 35°C before and after extensive washes with water. Positive control of invasive growth consisted of plates incubated at 37°C in a 5% CO 2 -enriched atmosphere. Likewise, colony wrinkling was estimated visually af-ter 48 h of growth either in air at 35°C or in a 5% CO 2 -enriched atmosphere at 37°C.
Quantification of membrane ergosterol. Ergosterol content was quantified by spectrophotometry by following an adaptation of the protocol described by Sanglard et al. (52) . Briefly, cells from a 5-ml overnight culture in YEPD medium were washed in distilled water, and nonsaponifiable sterols were extracted by incubation for 45 min at 80°C in KOH (15%)-EtOH (90%). The absorbance at 281.5 nm of the heptanic fraction, containing ergosterol, was determined and normalized per gram of cells. All experiments were performed in triplicate, and the differences between the strains were statistically analyzed by one-way analysis of variance (ANOVA) at a P value of 0.05 with Newmann correction, using Prism software (version 5.04; GraphPad).
RESULTS
Susceptibility of 241 C. albicans TF mutants to systemic antifungals. In an attempt to construct a collection of transcription factor mutants in C. albicans, almost 90% (241/274) of targeted ORFs encoding putative transcriptional regulators could be successfully inactivated, either by ORF deletion or, mostly, by transposon insertion. It is likely that the 33 remaining ORFs for which the inactivation was unsuccessful encode essential transcriptional regulators, since in most cases (27/33, ϳ82%) the inactivation of the ORF second allele resulted in gene duplications elsewhere in the genome. Thus, technical issues were responsible overall for less than 20% of inactivation failure.
In our drug susceptibility testing, decreased susceptibility to at least one of the antifungals tested could be reproduced with 48 TF mutants (see Table S1 for a detailed description of the TF mutant phenotypes). As shown in Table 1 , 23 mutants had an increased susceptibility to one single antifungal tested, while 10 TF mutants were simultaneously more susceptible to two antifungals than were their wild-type parents. Compared to the wild-type parents, six and five mutants were more susceptible to three and four antifungals, respectively.
Moreover, some mutants were more resistant to some of the antifungals than were the wild types. This was the case for orf19.5953 and orf19.6817 mutants, which were more resistant to FLC; for orf19.3193 and orf19.4662 mutants, which were more resistant to AMB; and for the orf19.6102 mutant, which was more resistant to CAS and FLC (Table 1) .
Selection and antifungal susceptibility of 13 C. albicans TF mutants. Thirteen mutants were selected for further investigation (Table 1) . Several criteria were applied to help to select for these TF mutants. First, among the mutants with an altered susceptibility to at least one antifungal, we chose to focus on mutants for which the phenotype was not previously reported. According to this selection, we discarded the mutant for orf19.2119 containing NDT80, a TF whose involvement in antifungal resistance is well established (11) . We also discarded the mutant for orf19.1032 (SKO1), which encodes a bZip TF, the deletion of which leads to increased susceptibility to CAS (48) . We also excluded mutants for orf19.1693 (CAS4), orf19.2331 (ADA2), orf19.4662 (RLM1), and orf19.4670 (CAS5), which are known to regulate CAS susceptibility (7), and the mutant for orf19.6817 (FCR1), encoding a zinc cluster TF and the deletion of which leads to increased resistance to FLC (62) .
We discarded mutants for six genes encoding putative or characterized general transcriptional regulators. These were the mutant for orf19.6011 (SIN3, a putative corepressor of transcription from RNA polymerase II [57] ), the mutant for orf19.4545 (SWI4, a TF involved in cell cycle progression [31] ), the mutant for orf19.5871 (putative ortholog of S. cerevisiae Swi/Snf component), the mutant for orf19.422 (SPT20, a leucine zipper-containing TF putatively a member of the SAGA complex), and mutants for orf19.5328 (GCN1) and orf19.6904 (GCN3), which are putatively involved in translational mechanisms.
We also discarded mutants for orf19.259, orf19.1253, orf19.5389, and orf19.5953, since they were found to be severely growth deficient, and mutants for which several clones obtained did not exhibit the same phenotypes in the presence of antifungals (i.e., mutants for orf19.1150, orf19.3201, orf19.6121, orf19.6514, orf19.6645, orf19.6753, and orf19.6861). Four mutants (i.e., orf19.2545, orf19.5676, orf19.6713, and orf19.6227 mutants) for which several clones also did not exhibit the same phenotype in the presence of antifungals were nevertheless selected for further investigations since the phenotype observed was reproducible between independent drug susceptibility tests.
We selected TFs of unknown functions in C. albicans (however, a putative function, inferred from the closest ortholog in S. cerevisiae, is attributed to most C. albicans genes). Thus, eight TF mutants, the function of which has been fully characterized in C. albicans, were not selected for further analysis. These were mutants for orf19.1358 (GCN4, a bZip TF involved in amino acid response [64] ), orf19.3127 (CZF1, a zinc cluster TF involved in regulation of white-opaque switching frequency [6, 71] ), orf19.3193 (FCR3, a bZip TF involved in iron homeostasis [58, 68] ), orf19.3683 (AGE3, involved in drug resistance and virulence [21, 39] ), orf19.3969 (encoding SFL2, a heat shock factor-like TF involved in filamentous growth and virulence [61] ), orf19.4318 (MIG1, a transcriptional repressor involved in carbon source utilization [69] ), orf19.4961 (STP2, involved in regulation of amino acid permease expression [41] ), and orf19.6124 (ACE2, a TF involved in regulation of morphogenesis [36] ).
Lastly, orf19.5445, orf19.1497, orf19.1007, orf19.1826, and orf19.3294 mutants were not selected for further study since in silico analyses as well as the function of the closest orthologs of these genes suggested that they did not encode true TFs despite the presence of a DBD. The last discarded mutant of this study was an orf19.3405 mutant, since this TF is involved in mouse organ colonization and is currently being investigated in a separate study in our laboratory (65) .
In order to verify that the phenotypes observed in the TF mutants of the collection were due to the deletion or the interruption of the targeted genes, we first reconstructed mutants for these 13 selected TFs in a new, independent background using the Urablaster strategy. We also constructed revertant strains for all these TF mutants by integration of a wild-type copy of the targeted gene at the RPS1 locus. After genotype verification by Southern blotting (see Fig. S1 to S4 in the supplemental material), the antifungal susceptibilities of these new, independent mutants were assessed by serial dilution assays. As illustrated in Fig. 1 and summarized in Table 1 , the phenotypes observed in the strains of the collection were verified in 10 out of 13 new, independent mutants. We were unable to confirm the phenotype for orf19.3865, orf19.5676, and orf19.2747 mutants. Some added phenotypes, like the decreased susceptibility of mutants for orf19.1168, orf19.7381, and orf19.6102 to FLC and the increased susceptibility of the mutant for orf19.5617 to FLC, were also observed.
Genes regulated by orf19.6102. We focused our investigations on the orf19.6102 mutant, since it exhibited resistance to FLC and CAS and thus was likely to contribute to understanding of crossresistance to drugs with different modes of action. Interestingly, while the present work was ongoing, this TF was identified as the regulator of carbonic anhydrase expression (16) and was consequently named RCA1 (for regulator of carbonic anhydrase). To characterize the function of this TF in addition to its role in CO 2 sensing, and to understand how it modulates antifungal susceptibility, we performed strand-specific RNAseq analyses to identify RCA1-regulated genes by comparing the transcriptomes of RCA1 mutant and revertant strains (raw RNAseq results are available in Table S5 in the supplemental material). Overall, the RCA1 regulon contained more than 450 genes (84 and 377 genes up-and downregulated more than 2-fold, respectively; see Table S5 for detailed gene list). Almost half of these RCA1-regulated genes have still-unknown functions in C. albicans.
Gene ontology (GO) analyses indicated that 23.1% of genes downregulated in rca1 mutant cells were involved in transport processes, 18.2% in response to various stimuli (chemicals, drugs, and stresses), and 18.6% in carbohydrate, lipid, and protein metabolism ( Fig. 2A) . Accordingly, transport functions were statistically significantly enriched among rca1-downregulated genes ( spotted onto antifungal-free or antifungal-containing media, and their susceptibilities were compared to that of the wild-type strain (PVY121) after 24 or 48 h of incubation at 35°C. In each panel, strains are arranged in the following order: wild type, homozygous mutant, and revertant isolate in the top, middle, and bottom rows, respectively. Serial dilution series corresponding to increased or decreased susceptibilities are boxed in white for better reading. The phenotypes of the mutants for orf19.3865, orf19.5676, and orf19.2747 of the TF mutant collection were not verified in the reconstructed mutants (see first three top serial dilution series).
were particularly overrepresented both as biological processes and biological functions. Moreover, in agreement with transport functions, a specific enrichment for membrane proteins was found.
Regarding upregulated genes, around a third of them (30.3%) were involved through RNA processing in protein synthesis, 30.4% in morphology and pathogenesis processes such as biofilm formation, hyphal growth, and cell adhesion, and 20.9% in response to various stimuli (Fig. 2B) . In good agreement with the high proportion of genes upregulated in rca1 mutant cells and involved in protein synthesis, a statistically significant enrichment for genes encoding ribosomal proteins, and more especially the mitochondrial ribosome, was found. Likewise, genes involved in biofilm formation as well as in cell adhesion were overrepresented among rca1-upregulated genes (Table 3) .
We observed a high number of genes (124/461, ϳ26%) either involved in iron metabolism or described as target genes of the CAATT-binding complex, including SEF1, SFU2, and HAP43, which are TFs regulating iron metabolism in C. albicans (10, 46) . Likewise, a total of 23 TF-encoding genes were differentially regulated following RCA1 deletion. Interestingly, 7 out of 18 downregulated TFs were involved in metabolic processes, including UGA33, SUC1, RGT1, STP3, CAT8, CSR1, and GAT1. The remaining genes were involved in morphology regulation (ZCF1, ZCF5, and ZCF26) or were of unknown function (ZCF15, ZCF16, ZCF21, ZCF22, orf19.173, orf19.2458, orf19.5975, and orf19.6888). Upregulated TFs were involved in morphogenesis (TEC1, BRG1, and CTA24), heat shock (CTA8), and tRNA synthesis (orf19.6903).
Validating the statistical strategy employed to identify the differentially regulated genes from RNAseq results (i.e., DEseq), a good correlation was found between RNAseq and qPCR for expression level of upregulated, downregulated, or unregulated genes (Fig. 3) .
Cottier et al. (16) addressed Rca1 occupancy by chromatin immunoprecipitation with microarray technology (ChIP-onchip) analysis. By merging the expression and ChIP-on-chip data, it is potentially possible to identify direct targets of Rca1. In this study, only 9 genes were overlapping between the two data sets, including orf19.3897, orf19.4251 (ZCF22), orf19.1117, orf19.5475, orf19.5475, orf19.3435, orf19.1721 (NCE103), orf19.4054 (CTA24), and orf19.3219. While NCE103 was confirmed as a direct Rca1 target, two other transcription factors, CTA24 (itself downregulated by Efg1) and ZCF22 (unknown function), were also regulated by Rca1, thus highlighting that Rca1 is part of a larger transcriptional network.
Rca1 is involved in bicarbonate homeostasis. In accordance with the observations made by Cottier et al. (16), we found that NCE103, the gene encoding carbonic anhydrase of C. albicans, was 6.3-fold downregulated in the rca1 mutant compared to the RCA1 revertant. The physiological role of carbonic anhydrase being first of all the production of bicarbonate from carbon dioxide, and given the important role of bicarbonate as a metabolic precursor in carboxylation reactions, RCA1 deletion may impact the growth capacity of C. albicans. Contrary to what was expected, monitoring RCA1 mutant and revertant cultures in both rich (YEPD) and synthetic (SC) liquid media did not reveal statistically significant growth deficiencies over a 48-h incubation period (Fig. 4A) . However, after 8 h of growth, rca1 mutant growth was decreased by 20 and 61% compared to the revertant in YEPD and SC media, respectively (Fig. 4B) . This growth deficiency could also be observed 
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FIG 2 Gene ontology (GO) distribution of C. albicans genes directly or indirectly regulated by RCA1.
The genes that were found to be upregulated (A) or downregulated (B) in rca1 mutant cells were analyzed with the GO Slim Mapper tool of the Candida Genome Database and classified by biological processes. The redundant occurrence of the most represented GO terms was calculated (total exceeds 100%, taking into account that several GO terms could be assigned to one single gene). Among both up-and downregulated genes, almost half of the genes had no associated GO terms. According to the involvement of RCA1 in metabolism toward regulation of NCE103 expression, almost 40% of genes downregulated in rca1 mutant cells were associated with a GO term involving general metabolism of the cell (e.g., transport and carbohydrate, lipid, and protein metabolic processes), and around 15% were involved in response to various signals (chemicals, stress, and drugs). Likewise, probably to counterbalance the decreased metabolic activity consecutive to RCA1 deletion, almost one-third of genes upregulated in rca1 mutant cells were involved in protein synthesis (RNA metabolism, translation, protein modification, and ribosome biogenesis). Moreover, in relation with rca1 mutant cell morphology, 20% of upregulated genes were involved in filamentous growth, biofilm formation, cell wall organization, and cell adhesion.
after 24 h of incubation at 35°C on both SC and YEPD solid media (Fig. 4C) . Rca1 is involved in hyphal development. The morphology of rca1 mutant cells was investigated by microscopic observations of cells grown under both yeast-and hypha-inducing conditions and compared to those of both the wild type and RCA1 revertant. Even under yeast-inducing conditions (i.e., YEPD medium at 30°C), the rca1 mutant cells were able to produce hyphae, while wild-type and revertant isolates grew only under the yeast form (Fig. 5A) . However, after the same incubation time, hyphae produced by rca1 mutant cells under yeast-inducing conditions were quantitatively less important (around 1 hypha for 20 blastoconidiae) than those produced by wild-type, rca1 mutant, or RCA1 revertant cells, which produced around 1 hypha per blastoconidia under the two hypha-inducing conditions (i.e., 5% CO 2 atmosphere at 37°C and supplementation of the medium with 10% FCS [ Fig. 5B and C]). The hyphal growth of the rca1 mutant correlated with both a strong wrinkling and enhanced invasive growth on YEPD medium at 30°C (Fig. 6 ). Consistent with these observations, a high number of genes regulated by RCA1 are involved in hyphal growth. For example, HWP1, ECE1, HGC1 and ALS3, which are specifically expressed during C. albicans hyphal growth, were among the most upregulated genes in the rca1 mutant (see Table  S5 in the supplemental material). RCA1 deletion has an indirect effect on antifungal susceptibility. Since transcriptome analyses did not reveal obvious genes potentially explaining the resistance of the rca1 mutant to FLC and CAS, the mechanisms responsible for these phenotypes were investigated by additional experiments. Regarding FLC resistance, we first quantified the plasma membrane content in ergosterol in the wild type, RCA1 mutant, and revertant by measuring absorbance at 282 nm of the nonsaponifiable sterols. As illustrated in Fig. 7 , deletion of RCA1 led to a significant decrease in ergosterol content (about 45%) compared to those of the wild-type and revertant isolates. This decreased ergosterol content was not correlated with an altered permeability of cells to FLC, since [ 3 H]FLC accumulation experiments did not reveal any statistical differences between wild-type and rca1 mutant strains (see Fig. S5 in the supplemental material). Regarding CAS resistance, cell wall composition modifications were assessed by testing the susceptibility of the rca1 mutant to several other cell wall-perturbing agents. Consistent with CAS resistance, the rca1 mutant cells were more susceptible to SDS and calcofluor white and more resistant to Congo red than the wild type (Fig. 8) . However, this altered susceptibility to cell wall-perturbing agents was not associated with modifications of the cell wall thickness or ultrastructure, as demonstrated by TEM experiments (see Fig. S6 in the supplemental material).
Adenylyl cyclase inhibition partially modulates Rca1 function. As suggested by transcriptome studies, it is likely that RCA1 regulates gene expression through modulation of the Cyr1/cAMP/ PKA pathway. Indeed, a high number of RCA1-regulated genes (93/462, ϳ20%) are also known targets of the TF Efg1, which is the downstream effector of the Cyr1/cAMP/PKA signaling pathway. To test this hypothesis, the different phenotypes exhibited by rca1 mutant cells were assessed in the presence of MDL12-330A, a competitive inhibitor of fungal adenylyl cyclases (32) . At 20 g/ ml, MDL12-330A almost totally prevented hyphal formation in rca1 mutant cells in YEPD medium at 30°C, which usually promotes yeast morphology (Fig. 5A) was stimulated by incubation at 37°C in the presence of 5% of CO 2 (Fig. 5B) , no quantitative or qualitative difference was visible between rca1 mutant cells in the presence or absence of the adenylyl cyclase inhibitor, which was not the case for wild-type and RCA1 revertant cells. As a matter of fact, when exposed to 5% CO 2 , these cells produced many fewer hyphae when MDL12-330A was added in the growth medium compared to the drug-free control (the hypha/cell ratio was close to 1:1 under standard hypha-inducing conditions, in contrast to 1:20 in the presence of 20 g/ml of MDL12-330A). Interestingly, an MDL12-330A repressing effect on hyphal development was not observed when hyphal induction was triggered by 10% serum (Fig. 5C) , and this was independent of the strain background.
Additionally, susceptibility of rca1 mutant cells to FLC and CAS was also tested in the presence of MDL12-330A (Fig. 8) . This adenylyl cyclase inhibitor (5 g/ml) had a strong effect on C. albicans susceptibility to FLC, since the wild type was more resistant to this drug when adenylyl cyclase was inhibited. In contrast, rca1 mutant cells exposed to MDL12-330A became more susceptible to FLC than strains containing RCA1. This effect was not observed 
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Invasive growth and macroscopic aspect of the rca1 mutant. Wild-type and rca1 mutant C. albicans isolates were streaked onto YEPD agar plates and incubated for 2 days at 35°C either in air or in a CO 2 -enriched atmosphere (5%) (A, left). Colonies were scraped off and plates carefully flushed with water (A, right). If in high ppCO 2 , both the wild type and rca1 mutant were able to invade the agar; only the rca1 mutant was able to do so in air. Likewise, only rca1 mutant colonies displayed a wrinkled morphology when incubated in low ppCO 2 , contrary to the case with high ppCO 2 , in which both wild-type and rca1 mutant colonies were highly wrinkled (B).
wild type rca1∆ RCA1rev with CAS. Hence, resistance of rca1 mutant to CAS was not relieved by adenylyl cyclase inhibition. Likewise, susceptibility of the rca1 mutant to cell wall-perturbing agents was not modified by the presence of MDL12-330A (Fig. 8) .
DISCUSSION
The identification of new effectors of the C. albicans response to antifungals constitutes one promising approach to the discovery of new fungus-specific targets and could serve as a basis for the development of new therapeutic strategies. Since any signal from the environment, and therefore antifungal stress, is integrated by signaling pathways which activate transcriptional regulators, the involvement of TFs with unknown functions in antifungal susceptibility may identify such new effectors. With this objective, we generated in collaboration with the Mitchell laboratory (Carnegie Mellon University) a collection of TF mutants in C. albicans by inactivation of all the ORFs of the C. albicans genome containing a DBD. This collection was screened for altered susceptibility to one representative molecule of the four classes of antifungals currently used to treat systemic Candida infections. After selection and phenotype confirmation of the most interesting candidate TFs, we functionally characterized one of them, the bZip TF encoded by orf19.6102, and we propose mechanisms for its involvement in antifungal susceptibility modulation. New transcriptional regulators affect antifungal susceptibility. Several phenotypes identified from our collection screening were already reported, thus validating our choice of screening strategy. For example, the large-scale CAS susceptibility testing performed by Bruno et al. (7) with about 90 TF mutants identified 6 TFs, among which 4 were identified here. Nevertheless, some discrepancies could be observed between our results and the phenotypes described in the study of Homann et al. (29) , which is to our knowledge the only large-scale study in which susceptibility to FLC and 5FC of C. albicans TF mutants was analyzed. That study tested susceptibility to FLC at concentrations differing from those used in ours. For example, we screened our collection at 2.5 g/ml of FLC, while Homann et al. (29) used 30.6 g/ml. For 5FC, the concentration used in our study was close to that published by the same group (4 versus 4.5 g/ml), but as stated by the authors, the deletion strategy employed to construct the mutants, which maintained leucine auxotrophy, interfered with 5FC susceptibility. Therefore, the discrepancies observed between our results and those obtained in the study of Homann et al. (29) could be partially due to the different concentration used for FLC and to the different gene inactivation strategies chosen in the case of 5FC. Overall, only the strongest phenotypes, for example, the increased susceptibility to FLC of the NDT80 mutant or the increased susceptibility to FLC of the mutant for orf19.3865, were found in common between our study and that of Homann et al. (29) .
Thirteen mutants were selected for further study (see Results for details on selection).
As we selected TFs with still-unknown functions in C. albicans, it was difficult at this point to propose an explanation for the involvement of these TFs in antifungal susceptibility. Thus, no direct evidence could be inferred from available computational or biological data regarding orf19.1168, orf19.6713, or orf19.6227 mutants. In other cases, the putative function of the TFs, mostly inferred from the closest orthologs in S. cerevisiae, hardly correlated with the observed phenotypes. This was the case for the DOT6 (orf19.2545) and orf19.5617 mutants, whose deletions led to increased susceptibility to 5FC. These ORFs are putatively involved in ribosome assembly (66) and transcription regulation (45), respectively. Mutants for STP4 (orf19.909) and ZFU2 (orf19.6781) were more susceptible to CAS; however, in S. cerevisiae, they are putatively involved in amino acid uptake (1) and lysine biosynthesis (22) , respectively. In one case, the putative function of the selected TFs deduced from the S. cerevisiae closest ortholog could explain the phenotype observed in C. albicans: the deletion of orf19.7371 led to increased susceptibility to AMB in C. albicans, and OAF3, its closest ortholog in S. cerevisiae, is involved in response to fatty acid availability (60) . Thus, fatty acid composition could alter plasma membrane permeability and sterol composition, thus interfering with AMB susceptibility.
During the completion of this study, the function of the TF encoded by orf19.7381, named Ahr1, was described (4). This TF is involved in Mcm1-dependent regulation of some adhesion-and hypha-related gene expression. In our hands, the AHR1 mutant was more susceptible to CAS and less susceptible to FLC than its isogenic wild type, a phenotype which could be explained by the high number of cell wall biosynthesis genes directly regulated by this TF, as demonstrated by ChIP-on-chip experiments performed by Askew et al. (4) .
The last of the 10 selected and verified TFs was orf19.6102 (RCA1). While this study was ongoing, this TF was identified as a regulator of carbonic anhydrase (NCE103) in response to carbon dioxide partial pressure (ppCO 2 ) (16).
Pleiotropic Rca1 functions. Consistent with the study published by Cottier et al. (16) , we found that carbonic anhydrase (NCE103) was downregulated upon RCA1 deletion. However, several discrepancies were found when comparing our results with those of Cottier et al. (16) . First, Cottier et al. (16) stated that the rca1 mutant was unable to form hyphae, while in our hands, it produced hyphae even under yeast-inducing conditions. This spontaneous filamentation of the rca1 mutant has also been observed in the work of Homann et al. (29) . Second, Cottier et al. (16) found that OCH1 and CHT2 were overexpressed as a result of RCA1 deletion, which was not the case with our mutant (see Calcofluor white 100 µg/ml Congo red 100 µg/ml SDS 0.02 %
FIG 8
Susceptibilities of C. albicans wild-type, rca1 mutant, and RCA1 revertant isolates to antifungals and cell wall-perturbing agents. RCA1 deletion led to a decreased susceptibility to CAS, FLC, and Congo red and to an increased susceptibility to calcofluor white and SDS. Inhibition of adenylyl cyclase had no effect on the susceptibility of the rca1 mutant to cell wall-perturbing agents but increased its susceptibility to FLC.
3). Third, we found that the rca1 mutant was more resistant to Congo red, and Cottier et al. (16) found the opposite phenotype. Although we have no experimental evidence regarding these discrepancies, they might be linked to the different gene inactivation strategies between the study of Cottier et al. (16) and our study. RCA1 genomic region is a very ORF-dense region, and the RCA1 ORF overlaps two other ORFs (MVD1 at the 3= end and orf19.6103 at the 5= end). In order to preserve these overlapping ORFs, Cottier et al. (16) deleted only the RCA1 section which is not overlapping the two adjacent ORFs, thus leaving a small unaltered fragment of RCA1 at the 5= end. We followed the same rationale, preserving the integrity of one allele of both MVD1 and orf19.6103 but deleting the entire RCA1 ORF of the second allele and consequently a small part of overlapping ORFs.
Rca1 participates in metabolism and energy production. Beyond these discrepancies and according to our observations and those of Cottier et al. (16) , Rca1 functions are broader than its only role in regulating carbonic anhydrase expression in a ppCO 2 -dependent manner. First of all, Rca1 participates in bicarbonate ion homeostasis by the control of Nce103 expression. In C. albicans, bicarbonate ions have a dual role. They participate in pH homeostasis, and they constitute important cofactors or cosubstrates for biosynthesis reactions requiring a carboxylation step or detoxification pathways. The last aspect is revealed in our rca1 mutant, which displayed slight growth deficiency, which was also observed in other studies (16, 29) . The rca1 mutant growth deficiency may be the consequence either of NCE103 downregulation and the consequent decreased bicarbonate ion concentration or of the downregulation of genes involved in organic substance transport, such as high-affinity glucose transporters, genes of fatty acid ␤-oxidation, or glyoxylate essential enzymes. Interestingly, we found that mitochondrial ribosome genes were statistically enriched among upregulated genes, probably to counterbalance the downregulation of genes involved in metabolism and energy production. These observations suggest that either RCA1 regulates genes involved in metabolism or RCA1 deletion may lead to the downregulation of other TFs, controlling the expression of such genes. In accordance with the second hypothesis, we found a total of 23 TFs (18 and 5 down-and upregulated, respectively), mainly involved in metabolism and morphology regulation, which were differentially expressed between the RCA1 mutant and revertant isolates.
Rca1 modulates the activity of the cAMP/PKA pathway. More importantly, bicarbonate ions, and therefore Rca1 through its control of NCE103 expression, are potent activators of adenylyl cyclase (Cyr1), which produces a signal molecule of major importance, cAMP. In turn, cAMP activates the regulatory subunit of protein kinase A (PKA) which phosphorylates its target effectors, among them the transcription factor Efg1, one of the master regulators of C. albicans morphology. In this study, we confirmed that the activation of this signaling pathway is modulated by Rca1, since we observed a downregulation of NCE103 in the rca1 mutant. Moreover, in comparing our RNAseq results with those of previous transcriptome studies investigating the Efg1 regulon (19, 55) , it was found that a high proportion of Rca1-regulated genes (93 out of 461 genes, ϳ20%) were also regulated by Efg1, thus further suggesting a pivotal role for Rca1 in this pathway. Another observation highlighting an Rca1-dependent control of Efg1 activity is the downregulation of 8 of the 10 genes of the fatty acid ␤-oxidation pathway found by RNAseq. These genes were described as transcriptionally controlled by Efg1 (55) .
Putative involvement of a transcriptional repressor in the Rca1 mode of action. When ppCO 2 is low, activation level of the cAMP/PKA signaling pathway is not sufficient to induce hyphal development. Therefore, it is likely that Rca1-dependent induction of carbonic anhydrase expression in ambient air serves only for bicarbonate homeostasis. In contrast, when ppCO 2 is high, Nce103 is no longer necessary for bicarbonate homeostasis since there is a spontaneous conversion from CO 2 to HCO 3 Ϫ . HCO 3 Ϫ concentration increases in yeast cells, triggering an activation of the cAMP/PKA pathway sufficient to activate Efg1 and to promote hyphal growth. We therefore wondered about the consequences of RCA1 deletion on C. albicans morphology. Contrary to our expectations, rca1 mutant cells grew in normal medium under the hyphal form (Fig. 5) . Interestingly, however, hyphal formation was quantitatively less important in rca1 mutant cells than in wildtype cells grown under hypha-inducing conditions such as serumsupplemented medium or 5% CO 2 at 37°C. Moreover, inhibition of Cyr1 in wild-type cells under hypha-inducing conditions mimicked a filamentation quantitatively comparable to that observed in rca1 mutant cells under yeast-inducing conditions. Therefore, RCA1 controls hyphal development not only through the cAMP/ PKA/Efg1 signaling pathway but also probably through a yet-unidentified putative transcriptional repressor. Several experimental results support this hypothesis. First, the mechanism of transcriptional repression is well established in C. albicans morphogenesis control, in which the WD40-repeat protein-protein interaction domain present in the transcriptional repressor Tup1 is able to bind TFs, themselves targeting the repressor complex to the promoters of hypha-specific genes which are subsequently repressed. The nature of the TF complexed with Tup1 can vary depending on environmental conditions. Thus, interactions between Tup1 and the TF Nrg1, Rfg1 (34), or Tcc1 (35) have been documented. Moreover, some Tup1-regulated genes are not dependent on any of its known partners, suggesting either that Tup1 is able to regulate the expression of hypha-specific genes without interacting with a DBD-containing protein or that Tup1 can interact with a still-unknown TF(s). Reinforcing the second hypothesis, Kadosh and Johnson (34) concluded in their study describing the role of Tup1 in the regulation of C. albicans morphology that Tup1 is likely to bind still-unknown DNA binding proteins. From our results, we propose that Rca1 would be one of these TFs potentially interacting with Tup1 to repress the expression of hyphaspecific genes. Accordingly, we compared the Rca1 regulon with those of Tup1, Nrg1, and Rfg1 (34) and found a core of upregulated genes (HWP1, ALS3, ECE1, and IHD1) in the four hyphal repressor mutants. More interestingly, the hypha-specific genes HGC1, ECE1, and RBT5 are commonly upregulated in Rca1 and Tup1 mutants (25) but, to our knowledge, are not directly regulated by Efg1. This suggests that in wild-type C. albicans, both Efg1-and Tup1-dependent Rca1-mediated inductions of hyphal development are necessary to reach the filamentation level observed in the presence of high ppCO 2 . As a matter of fact, the poor overlap between Rca1 genome occupancy and Rca1 expression data highlights that Rca1 controls gene expression mostly by indirect interactions.
Interestingly, we noticed that almost 27% of Rca1-regulated genes are also known targets of Hap43, which belongs to the CCAAT-binding complex regulating iron homeostasis in C. albicans (10, 58) . Hap43 has been demonstrated to interact with Tup1 (30) . This overlapping regulation between Rca1 and Hap43 targets further suggests that Tup1 may be involved in the mode of action of Rca1. Confirming the involvement of Rca1 in iron homeostasis, the rca1 mutant had an increased susceptibility to the iron chelator bathophenanthroline disulfonic acid (see Fig. S7 in the supplemental material).
From previous observations combined with our findings, we are now able to draw a model for the signaling cascade controlling C. albicans morphology in response to ppCO 2 (Fig. 9) . In ambient air, Rca1 induces NCE103 expression, which participates in bicarbonate homeostasis and maintains the cAMP/PKA signaling pathway at a level not sufficient to promote hyphal growth. Moreover, Rca1 together with a putative transcriptional repressor may further prevent the expression of hypha-specific genes. When ppCO 2 increases, a high level of bicarbonate activates the cAMP/PKA signaling pathway and subsequently the TF Efg1, and Rca1 inactivation relieves the inhibition exercised on the expression of hyphaspecific genes through its interaction with the repressor. Confirming this hypothetical mechanism, we can explain the quantitatively less important hyphal formation observed following RCA1 deletion since the hyphal formation is mainly due to the relief of this inhibition via the interaction between Rca1 and the putative transcriptional repressor on hypha-specific genes. However, we were also able to demonstrate that inhibition of adenylyl cyclase impaired RCA1 deletion-dependent filamentation, confirming that this phenomenon is still mediated by the cAMP/PKA pathway.
Rca1 indirectly modulates antifungal susceptibility. The resistance of the rca1 mutant to FLC and CAS could not be directly deduced from transcriptional results. Indeed, none of the genes known to be up-or downregulated by resistance to azoles (e.g., ERG11, CDR1, CDR2, or MDR1) or echinocandin (CAS5, FKS1, or FKS2) were found to be differentially regulated between the RCA1 mutant and revertant strains. Therefore, this resistance may be the consequence of indirect mechanisms.
Regarding FLC resistance, we found a significant decrease in ergosterol content in rca1 mutant cells. This decreased ergosterol content was not a consequence of a downregulation of ergosterol biosynthetic pathway genes. However, transcriptome analysis identified some lipid metabolism genes, including DPP1 (diacyglycerol pyrophosphate phosphatase, involved in phospholipid biosynthesis) which were downregulated. DPP1 downregulation has been associated with FLC resistance in C. albicans (49) . It is likely that FLC resistance of the rca1 mutant is the consequence of the modification of the activity level of the cAMP/PKA signaling pathway. A link between FLC susceptibility and cAMP has also Ϫ synthesis is not sufficient to induce an activation of the cAMP/PKA/Efg1 signaling pathway (absence of activation is represented by dotted lines). Therefore, Efg1-dependent hypha-specific genes are not expressed. Moreover, Rca1 interaction with a putative transcriptional repressor further prevents the expression of these genes. Consequently, C. albicans grows under the yeast form. RCA1 deletion (B) leads to the downregulation of NCE103 and to a subsequent growth deficiency. Moreover, repression exercised by the interaction between Rca1 and the putative transcriptional repressor on hypha-specific genes is relieved, and thus C. albicans forms hyphae. The deregulation of cAMP/PKA/Efg1-dependent gene expression is responsible for FLC resistance, while the deregulation of Rca1/repressor-dependent genes expression is responsible for CAS resistance. When ppCO 2 increases (C), Rca1 is inactive and NCE103 is no longer transcribed. However, the spontaneous conversion from CO 2 into HCO 3 Ϫ is sufficient to increase the bicarbonate concentration within C. albicans cells. The high HCO 3 Ϫ concentration reaches a level that activates adenylyl cyclase (Cyr1). Cyr1 then converts ATP into cAMP, which, in turn, activates the protein kinase A (PKA). PKA activates the transcription factor Efg1, which induces the expression of hypha-specific genes. Moreover, Rca1 inactivation relieves its interaction with a transcriptional repressor, which further induces the expression of hypha-specific genes. This allows hyphal development.
been suggested in another study in which both C. albicans and S. cerevisiae adenylyl cyclase mutants were found to be more susceptible to azole and other sterol biosynthesis inhibitors than wildtype isolates (32) . The genes responsible for decreased ergosterol content remain to be identified.
The rca1 mutant also exhibited resistance to CAS. Detailed phenotypic characterization confirmed an altered cell wall composition, since RCA1 deletion led to an increased susceptibility to calcofluor white and to a decreased susceptibility to Congo red, two compounds binding the main cell wall polysaccharides, chitin and ␤-glucans, respectively. Additionally, the rca1 mutant was also more susceptible to SDS, reflecting an impaired function of the cell wall as a physical barrier. Accordingly, transcriptional analysis identified several regulated genes involved in cell wall polysaccharide biogenesis or modification (Table 4) . Unfortunately, the modification of the expression of these genes involved in cell wall organization and/or biogenesis was not accompanied by a modification of the cell wall ultrastructure, as shown by transmission electron microscopy (see Fig. S6 in the supplemental material).
Transcriptional results demonstrated that Rca1 modulates the activity of the cAMP signaling pathway through its control on NCE103 expression. Accordingly, it has been demonstrated that the constitutive activation of this pathway obtained by PDE2 deletion results in increased susceptibility to cell wall-perturbing agents such as calcofluor white or SDS and decreases cell wall thickness by 25% (33) . However, Cyr1 inhibition had no consequence on rca1 mutant resistance to CAS, suggesting that the cAMP signaling pathway may not be responsible for this phenotype. Accordingly, both the efg1 mutant and the efg1/rca1 double mutant were resistant to FLC, while only the efg1/rca1 double mutant was resistant to CAS (see Fig. S7 in the supplemental material). This further suggests that CAS susceptibility would not be Efg1 dependent but, rather, mediated by Rca1 through a putative interaction with Tup1.
In conclusion, the screening of a collection of C. albicans TF mutants for altered susceptibility to systemic antifungals allowed the identification of several TFs with still-unreported functions in this process. The functional characterization of Rca1 in altered antifungal susceptibility was attempted and integrated other Rca1 functions. The experimental demonstration of an interaction between Rca1 and Tup1 could validate in the future our hypothesis regarding the Rca1 mode of action. Overall, this TF constitutes a possible candidate for the development of new therapeutic strategies, since it is at the crossroad between host sensing (by triggering an adapted response to high ppCO 2 ), antifungal response (by controlling cell wall-related gene expression and modulating cAMP signaling pathway activity), and virulence (by controlling hyphal development and iron homeostasis). The modulation of the activity of this TF or of its downstream effectors could potentially affect C. albicans pathogenicity or in vivo response to antifungals. Impairing Rca1 downstream effectors responsible for antifungal resistance or hyphal development either increases C. albicans susceptibility to antifungals or blocks its ability to switch to hyphal form and therefore may compromise the survival of this important pathogen in the host. Finally, the functional characterization of the other TFs identified during the screening of the collection will be undertaken and may facilitate the discovery of potential new antifungal targets. 
